NCT07267026
- Conditions
- FSGS, MCD, Macular dystrophy, corneal type 1
- Locations
-
- Q-Pharm Pty Ltd. Herston, Queensland, Australia
Clinical trial condition
Explore clinical trials studying MCD. Study availability and eligibility vary by location and protocol.
NCT07267026
NCT06983028
NCT04571658
NCT05650619
NCT04009668